Abstract
The current understanding and effective treatment of liver disease is far from satisfactory. Liver organoids and liver buds (LBs) transforming cell culture from two dimensions(2D) to three dimensions(3D) has provided infinite possibilities for stem cells to use in clinic. Recent technological advances in the 3D culture have shown the potentiality of liver organoids and LBs as the promising tool to model in vitro liver diseases. The induced LBs and liver organoids provide a platform for cell-based therapy, liver disease models, liver organogenesis and drugs screening. And its genetic heterogeneity supplies a way for the realization of precision medicine.
Similar content being viewed by others
References
Loessner, D., Stok, K. S., Lutolf, M. P., et al. (2010). Bioengineered 3D platform to explore cell–ECM interactions and drug resistance of epithelial ovarian cancer cells. BIOMATERIALS., 31, 8494–8506.
Wong, D. J., Khavari, P. A., Chow, J. M., et al. (2010). Invasive three-dimensional organotypic neoplasia from multiple normal human epithelia. Nature Medicine, 16, 1450–1455.
Ng, S. S., Saeb-Parsy, K., Blackford, S., et al. (2018). Human iPS derived progenitors bioengineered into liver organoids using an inverted colloidal crystal poly (ethylene glycol) scaffold. BIOMATERIALS., 182, 299–311.
Peterson, S. E., & Loring, J. F. (2014). Genomic instability in pluripotent stem cells: Implications for clinical applications. The Journal of Biological Chemistry, 289, 4578–4584.
Lund, R. J., Närvä, E., & Lahesmaa, R. (2012). Genetic and epigenetic stability of human pluripotent stem cells. Nature Reviews. Genetics, 13, 732–744.
Knouse, K. A., Lopez, K. E., Bachofner, M., et al. (2018). Chromosome segregation Fidelity in epithelia requires tissue architecture. CELL., 175, 200–211.
Takebe, T., Sekine, K., Kimura, M., et al. (2017). Massive and reproducible production of liver buds entirely from human pluripotent stem cells. Cell Reports, 21, 2661–2670.
Camp, J. G., & Sekine, K. (2017). Gerber T, et al. NATURE: Multilineage communication regulates human liver bud development from pluripotency.
Lancaster, M. A., & Knoblich, J. A. (2014). Organogenesis in a dish: Modeling development and disease using organoid technologies. SCIENCE., 345, 1247125.
Li, M., & Izpisua Belmonte, J. C. (2019). Organoids — Preclinical models of human disease. The New England Journal of Medicine., 380, 569–579.
Takebe, T., & Wells, J. M. (2019). Organoids by design. SCIENCE., 364, 956–959.
Barker, N., van Es, J. H., Kuipers, J., et al. (2007). Identification of stem cells in small intestine and colon by marker gene Lgr5. NATURE., 449, 1003–1007.
de Lau, W., Barker, N., Low, T. Y., et al. (2011). Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. NATURE., 476, 293–297.
Huch, M., & Koo, B. K. (2015). Modeling mouse and human development using organoid cultures. DEVELOPMENT., 142, 3113–3125.
Takasato, M., Er, P. X., Chiu, H. S., et al. (2015). Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. NATURE., 526, 564–568.
Schwank, G., Koo, B. K., Sasselli, V., et al. (2013). Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell, 13, 653–658.
Boj, S. F., Hwang, C., Baker, L. A., et al. (2015). Organoid models of human and mouse ductal pancreatic Cancer. CELL., 160, 324–338.
van de Wetering, M., Francies, H. E., Francis, J. M., et al. (2015). Prospective derivation of a living organoid biobank of colorectal Cancer patients. CELL., 161, 933–945.
Lancaster, M. A., Renner, M., Martin, C., et al. (2013). Cerebral organoids model human brain development and microcephaly. NATURE., 501, 373–379.
Forbester, J. L., Goulding, D., Vallier, L., et al. (2015). Interaction of salmonella enterica Serovar typhimurium with intestinal organoids derived from human induced pluripotent stem cells. Infection and Immunity, 83, 2926–2934.
McCracken, K. W., Catá, E. M., Crawford, C. M., et al. (2014). Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. NATURE., 516, 400–404.
Lemos, D. R., McMurdo, M., Karaca, G., Wilflingseder, J., Leaf, I. A., Gupta, N., Miyoshi, T., Susa, K., Johnson, B. G., Soliman, K., Wang, G., Morizane, R., Bonventre, J. V., & Duffield, J. S. (2018). Interleukin-1 Activates a MYC-Dependent Metabolic Switch in Kidney Stromal Cells Necessary for Progressive Tubulointerstitial Fibrosis. Journal of the American Society of Nephrology, 29(6), 1690–1705.
Fong, E. L. S., Toh, T. B., Lin, Q. X. X., Liu, Z., Hooi, L., Mohd Abdul Rashid, M. B., Benoukraf, T., Chow, E. K.-H., Huynh, T. H., & Yu, H. (2018). Generation of matched patient-derived xenograft in vitro-in vivo models using 3D macroporous hydrogels for the study of liver cancer. Biomaterials, 159, 229–240.
Kanteti, R., Mirzapoiazova, T., Riehm, J. J., Dhanasingh, I., Mambetsariev, B., Wang, J., Kulkarni, P., Kaushik, G., Seshacharyulu, P., Ponnusamy, M. P., Kindler, H. L., Nasser, M. W., Batra, S. K., & Salgia, R. (2018). Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma. Cancer Biology & Therapy, 19(4), 316–327.
Takebe, T., Sekine, K., Enomura, M., et al. (2013). Vascularized and functional human liver from an iPSC-derived organ bud transplant. NATURE., 499, 481–484.
Shinozawa, T., Yoshikawa, H. Y., & Takebe, T. (2016). Reverse engineering liver buds through self-driven condensation and organization towards medical application. Developmental Biology, 420, 221–229.
Li, J., Xing, F., Chen, F., et al. (2018). Functional 3D human liver bud assembled from MSC-derived multiple liver cell lineages. Cell Transplantation, 1504309615.
Koui, Y., Kido, T., Ito, T., et al. (2017). An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells. Stem Cell Reports, 9, 490–498.
Zhang, R. R., Koido, M., Tadokoro, T., et al. (2018). Human iPSC-derived posterior gut progenitors are expandable and capable of forming gut and liver organoids. Stem Cell Reports, 10, 780–793.
Ayabe, H., Anada, T., Kamoya, T., et al. (2018). Optimal hypoxia regulates human iPSC-derived liver bud differentiation through intercellular TGFB signaling. Stem Cell Reports, 11, 306–316.
Ang, L. T., Tan, A. K. Y., Autio, M. I., et al. (2018). A roadmap for human liver differentiation from pluripotent stem cells. Cell Reports, 22, 2190–2205.
Takebe, T., Enomura, M., Yoshizawa, E., et al. (2015). Vascularized and complex organ buds from diverse tissues via mesenchymal cell-driven condensation. Cell Stem Cell, 16, 556–565.
Takebe, T., Zhang, R., Koike, H., et al. (2014). Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature Protocols, 9, 396–409.
Chen, K. G., Mallon, B. S., McKay, R. D. G., et al. (2014). Human pluripotent stem cell culture: Considerations for maintenance, expansion, and therapeutics. Cell Stem Cell, 14, 13–26.
Cherry, A. B. C., & Daley, G. Q. (2012). Reprogramming cellular identity for regenerative medicine. CELL., 148, 1110–1122.
Lemaigre, F. P. (2009). Mechanisms of liver development: Concepts for understanding liver disorders and Design of Novel Therapies. GASTROENTEROLOGY., 137, 62–79.
Lin, Y., Fang, Z.-P., Liu, H.-J., Wang, L.-J., Cheng, Z., Tang, N., Li, T., Liu, T., Han, H.-X., Cao, G., Liang, L., Ding, Y.-Q., & Zhou, W.-J. (2017). HGF/R-spondin1 rescues liver dysfunction through the induction of Lgr5+ liver stem cells. Nature Communications, 8(1). https://doi.org/10.1038/s41467-017-01341-6.
McLin, V. A., Rankin, S. A., & Zorn, A. M. (2007). Repression of Wnt/ -catenin signaling in the anterior endoderm is essential for liver and pancreas development. DEVELOPMENT., 134, 2207–2217.
Li, C., Wu, X., Tong, J., et al. (2015). Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy. Stem Cell Research & Therapy, 6.
Secunda, R., Vennila, R., Mohanashankar, A. M., et al. (2015). Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: A comparative study. CYTOTECHNOLOGY., 67, 793–807.
Uezumi, A., Ojima, K., Fukada, S., et al. (2006). Functional heterogeneity of side population cells in skeletal muscle. BIOCHEM BIOPH RES CO., 341, 864–873.
Laino, G., Graziano, A., D'Aquino, R., et al. (2006). An approachable human adult stem cell source for hard-tissue engineering. Journal of Cellular Physiology, 206, 693–701.
Santhagunam, A., Santos, F. D., Madeira, C., et al. (2014). Isolation and ex vivo expansion of synovial mesenchymal stromal cells for cartilage repair. CYTOTHERAPY., 16, 440–453.
Frausin, S., Viventi, S., Verga Falzacappa, L., et al. (2015). Wharton's jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research. Acta Histochemica, 117, 329–338.
Al-Nbaheen, M., Vishnubalaji, R., Ali, D., et al. (2013). Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential. Stem Cell Reviews and Reports, 9, 32–43.
Centeno, C. J., Al-Sayegh, H., Freeman, M. D., et al. (2016). A multi-center analysis of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous stem cell therapy for orthopaedic conditions. International Orthopaedics, 40, 1755–1765.
English, K. (2013). Mechanisms of mesenchymal stromal cell immunomodulation. Immunology and Cell Biology, 91, 19–26.
Dahl, J., Duggal, S., Coulston, N., et al. (2008). Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum. The International Journal of Developmental Biology., 52, 1033–1042.
Jeon, Y., Kim, J., Cho, J. H., et al. (2016). Comparative analysis of human mesenchymal stem cells derived from bone marrow, placenta, and adipose tissue as sources of cell therapy. Journal of Cellular Biochemistry, 117, 1112–1125.
Heo, J. S., Choi, Y., Kim, H. S., et al. (2016). Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. International Journal of Molecular Medicine, 37, 115–125.
Hass, R., Kasper, C., Böhm, S., et al. (2011). Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell communication and signaling : CCS., 9, 12.
Si Tayeb, K., Noto, F. K., Nagaoka, M., et al. (2010). Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells. HEPATOLOGY., 51, 297–305.
Fong, E. L. S., Harrington, D. A., Farach-Carson, M. C., & Yu, H. (2016). Heralding a new paradigm in 3D tumor modeling. Biomaterials, 108, 197–213.
Zhang, X., Liu, S., Wang, Y., Hu, H., Li, L., Wu, Y., Cao, D., Cai, Y., Zhang, J., & Zhang, X. (2019). Interleukin-22 regulates the homeostasis of the intestinal epithelium during inflammation. International Journal of Molecular Medicine, 43(4), 1657–1668.
Huch, M., Dorrell, C., Boj, S. F., et al. (2013). In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. NATURE., 494, 247–250.
Broutier, L., Andersson-Rolf, A., Hindley, C. J., et al. (2016). Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation. Nature Protocols, 11, 1724–1743.
Fiorotto, R., Amenduni, M., Mariotti, V., et al. (2018). Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
Tian, M., Neil, J. R., & Schiemann, W. P. (2011). Transforming growth factor-β and the hallmarks of cancer. Cellular Signalling, 23, 951–962.
Bierie, B., & Moses, H. L. (2010). Transforming growth factor beta (TGF-β) and inflammation in cancer. CYTOKINE GROWTH F R., 21, 49–59.
Vascular Endothelial Growth Factor.
Wang, Y., Wang, H., Deng, P., et al. (2018). In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system. Lab on a Chip, 18, 3606–3616.
Broutier, L., Mastrogiovanni, G., Verstegen, M. M., et al. (2017). Human primary liver cancer–derived organoid cultures for disease modeling and drug screening. Nature Medicine, 23, 1424–1435.
Kruitwagen, H. S., Oosterhoff, L. A., Vernooij, I. G. W. H., et al. (2017). Long-term adult feline liver organoid cultures for disease modeling of hepatic steatosis. Stem Cell Reports, 8, 822–830.
Nie, Y., Zheng, Y., Miyakawa, K., et al. (2018). Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells. EBIOMEDICINE., 35, 114–123.
Takebe, T., Sekine, K., Kimura, M., et al. (2017). Massive and reproducible production of liver buds entirely from human pluripotent stem cells. Cell Reports, 21, 2661–2670.
Takebe, T., Sekine, K., Enomura, M., et al. (2013). Vascularized and functional human liver from an iPSC-derived organ bud transplant. NATURE., 499, 481–484.
Ang, L. T., Tan, A. K. Y., Autio, M. I., et al. (2018). A roadmap for human liver differentiation from pluripotent stem cells. Cell Reports, 22, 2190–2205.
Spence, J. R., Mayhew, C. N., Rankin, S. A., et al. (2010). Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. NATURE., 470, 105–109.
Tremblay, K. D., & Zaret, K. S. (2005). Distinct populations of endoderm cells converge to generate the embryonic liver bud and ventral foregut tissues. Developmental Biology, 280, 87–99.
Vyas, D., Baptista, P. M., Brovold, M., et al. (2018). Self-assembled liver organoids recapitulate hepatobiliary organogenesisin vitro. HEPATOLOGY., 67, 750–761.
Andersson, E. R., Chivukula, I. V., Hankeova, S., et al. (2018). Mouse model of Alagille syndrome and mechanisms of Jagged1 missense mutations. GASTROENTEROLOGY., 154, 1080–1095.
Huch, M., Gehart, H., van Boxtel, R., et al. (2015). Long-term culture of genome-stable bipotent stem cells from adult human liver. CELL., 160, 299–312.
Cheon, D. J., & Orsulic, S. (2011). Mouse models of cancer. Annual Review of Pathology, 6, 95–119.
Caponigro, G., & Sellers, W. R. (2011). Advances in the preclinical testing of cancer therapeutic hypotheses. Nature Reviews. Drug Discovery, 10, 179–187.
Trepo, C., Chan, H. L., & Lok, A. (2014). Hepatitis B virus infection. LANCET., 384, 2053–2063.
Liang, T. J., Block, T. M., McMahon, B. J., et al. (2015). Present and future therapies of hepatitis B: From discovery to cure. HEPATOLOGY., 62, 1893–1908.
Pitera, J. E., Woolf, A. S., Basson, M. A., et al. (2012). Sprouty1 haploinsufficiency prevents renal agenesis in a model of Fraser syndrome. Journal of the American Society of Nephrology : JASN., 23, 1790–1796.
Chen, Y., Huang, S. X., de Carvalho, A. L. R. T., et al. (2017). A three-dimensional model of human lung development and disease from pluripotent stem cells. Nature Cell Biology, 19, 542–549.
Schutte, M., Fox, B., Baradez, M., et al. (2011). Rat primary hepatocytes show enhanced performance and sensitivity to acetaminophen during three-dimensional culture on a polystyrene scaffold designed for routine use. ASSAY DRUG DEV TECHN., 9, 475–486.
Berthiaume, F., Moghe, P. V., Toner, M., et al. (1996). Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: Hepatocytes cultured in a sandwich configuration. The FASEB Journal, 10, 1471–1484.
Fu, D., Wakabayashi, Y., Lippincott-Schwartz, J., et al. (2011). Bile acid stimulates hepatocyte polarization through a cAMP-Epac-MEK-LKB1-AMPK pathway. Proceedings of the National Academy of Sciences., 108, 1403–1408.
Dunn, J. C., Tompkins, R. G., & Yarmush, M. L. (1991). Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnology Progress, 7, 237–245.
Kern, A., Bader, A., Pichlmayr, R., et al. (1997). Drug metabolism in hepatocyte sandwich cultures of rats and humans. Biochemical Pharmacology, 54, 761–772.
Schyschka, L., Sánchez, J. J. M., Wang, Z., et al. (2013). Hepatic 3D cultures but not 2D cultures preserve specific transporter activity for acetaminophen-induced hepatotoxicity. Archives of Toxicology, 87, 1581–1593.
Kimoto, E., Walsky, R., Zhang, H., et al. (2012). Differential modulation of cytochrome P450 activity and the effect of 1-Aminobenzotriazole on hepatic transport in Sandwich-cultured human hepatocytes. Drug Metabolism and Disposition, 40, 407–411.
Xu, J. J., Henstock, P. V., Dunn, M. C., et al. (2008). Cellular imaging predictions of clinical drug-induced liver injury. Toxicological Sciences, 105, 97–105.
Langer, R., & Tirrell, D. A. (2004). Designing materials for biology and medicine. NATURE., 428, 487–492.
Du, Y., Han, R., Wen, F., et al. (2008). Synthetic sandwich culture of 3D hepatocyte monolayer. BIOMATERIALS., 29, 290–301.
Haycock JW. 3D cell culture: a review of current approaches and techniques. Methods in molecular biology (Clifton, N.J.). 2011;695:1.
Ramaiahgari, S. C., den Braver, M. W., Herpers, B., et al. (2014). A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies. Archives of Toxicology.
Au, S. H. (2014). Chamberlain MD, Mahesh S, et al. Hepatic organoids for microfluidic drug screening. LAB CHIP., 14, 3290.
Saheli, M., Sepantafar, M., Pournasr, B., et al. (2018). Three-dimensional liver-derived extracellular matrix hydrogel promotes liver organoids function. Journal of Cellular Biochemistry, 119, 4320–4333.
Ramachandran, S. D., Schirmer, K., Münst, B., et al. (2015). In vitro generation of functional liver organoid-like structures using adult human cells. PLoS One, 10, e139345.
Sendi H, Mead I, Wan M, et al. miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling. PLOS ONE. 2018;13:e200847.
Dijkstra, K. K., Cattaneo, C. M., Weeber, F., et al. (2018). Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids. CELL., 174, 1586–1598.
Palucka, A. K., & Coussens, L. M. (2016). The basis of Oncoimmunology. CELL., 164, 1233–1247.
Neal, J. T., Li, X., Zhu, J., et al. (2018). Organoid modeling of the tumor immune microenvironment. CELL., 175, 1972–1988.
Yanagi, Y., Nakayama, K., Taguchi, T., et al. (2017). In vivo and ex vivo methods of growing a liver bud through tissue connection. SCI REP-UK., 7.
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians, 68, 394–424.
Borst, P. (2012). Cancer drug pan-resistance: Pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what? Open Biology, 2, 120066.
Vlachogiannis, G., Hedayat, S., Vatsiou, A., et al. (2018). Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. SCIENCE., 359, 920–926.
van de Wetering, M., Francies, H. E., Francis, J. M., et al. (2015). Prospective derivation of a living organoid biobank of colorectal Cancer patients. CELL., 161, 933–945.
Boj, S. F., Hwang, C., Baker, L. A., et al. (2015). Organoid models of human and mouse ductal pancreatic Cancer. CELL., 160, 324–338.
Gao, D., Vela, I., Sboner, A., et al. (2014). Organoid cultures derived from patients with advanced prostate Cancer. CELL., 159, 176–187.
Sachs, N., de Ligt, J., Kopper, O., et al. (2018). A living biobank of breast Cancer organoids captures disease heterogeneity. CELL., 172, 373–386.
Skardal, A., Devarasetty, M., Rodman, C., et al. (2015). Liver-tumor hybrid organoids for modeling tumor growth and drug response in vitro. Annals of Biomedical Engineering, 43, 2361–2373.
Li, L., Knutsdottir, H., Hui, K., et al. (2019). Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity. JCI Insight., 4.
Asai, A., Aihara, E., Watson, C., et al. (2017). Paracrine signals regulate human liver organoid maturation from induced pluripotent stem cells. DEVELOPMENT., 144, 1056–1064.
Peng, W. C., Logan, C. Y., Fish, M., et al. (2018). Inflammatory Cytokine TNFα promotes the long-term expansion of primary hepatocytes in 3D culture. CELL., 175, 1607–1619.
Saheli, M., Sepantafar, M., Pournasr, B., et al. (2018). Three-dimensional liver-derived extracellular matrix hydrogel promotes liver organoids function. Journal of Cellular Biochemistry, 119, 4320–4333.
Sepantafar, M., Maheronnaghsh, R., Mohammadi, H., et al. (2017). Engineered hydrogels in Cancer therapy and diagnosis. Trends in Biotechnology, 35, 1074–1087.
Caliari, S. R., & Burdick, J. A. (2016). A practical guide to hydrogels for cell culture. Nature Methods, 13, 405–414.
Chen, Y., Feng, J., Zhao, S., Han, L., Yang, H., Lin, Y., & Rong, Z. (2018). Long-Term Engraftment Promotes Differentiation of Alveolar Epithelial Cells from Human Embryonic Stem Cell Derived Lung Organoids. Stem Cells and Development, 27(19), 1339–1349.
Guye, P., Ebrahimkhani, M. R., Kipniss, N., Velazquez, J. J., Schoenfeld, E., Kiani, S., Griffith, L. G., & Weiss, R. (2016). Genetically engineering self-organization of human pluripotent stem cells into a liver bud-like tissue using Gata6. Nature Communications, 7(1). https://doi.org/10.1038/ncomms10243.
Acknowledgements
We thank Dr. Xiaoping Xu and Yuan Chen for help in discussion on field liver bud and organoid.
Availability of Data and Materials
Not applicable.
Funding
This work was supported by the National Natural Science Foundation of China (81470875), Science and Technology Planning Project of Guangdong Province (2015B020229002, 2014B020227002), and the Natural Science Foundation of Guangdong Province (2014A030312013).
Author information
Authors and Affiliations
Contributions
Weng Jun conceptualized the discussions. Fanhong Zeng wrote the manuscript under the supervision of Gao Yi. Yue Zhang and Xu Han edited the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics Approval and Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Competing Interests
The authors declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Fanhong Zeng, Yue Zhang, Xu Han, Jun Weng, and Yi Gao are co-authors
Rights and permissions
About this article
Cite this article
Zeng, F., Zhang, Y., Han, X. et al. Liver Buds and Liver Organoids: New Tools for Liver Development, Disease and Medical Application. Stem Cell Rev and Rep 15, 774–784 (2019). https://doi.org/10.1007/s12015-019-09909-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-019-09909-z